Eli Lilly’s Zepbound proved more effective than Novo Nordisk’s Wegovy in a new head-to-head trial, though both medications ...

There is growing evidence that Ozempic and other GLP-1 receptor agonist drugs might help people drink less alcohol, but more research is needed.

China’s Commerce Ministry said Wednesday that it would take legal action against any organization or individual assisting the US in discouraging the use of China’s advanced semiconductors.